Identification |
Name: | Piperazine,1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)- |
Synonyms: | Piperazine,1-cinnamyl-4-(diphenylmethyl)- (6CI,7CI,8CI);1-(3-Phenylallyl)-4-(diphenylmethyl)piperazine;1-Cinnamyl-4-(diphenylmethyl)piperazine;1-Diphenylmethyl-4-cinnamoylpiperazine;516MD;Aplactan;Apotomin;Carecin;Cerepar;Cinarizine;Cinnacet;Cinnipirine;Denapol;Dimitronal;Folcodal;Glanil;Ixterol;Labyrin;Marisan;Mitronal;Olamin;Sepan;Spaderizine;Stutgeron;Toliman; |
CAS: | 298-57-7 |
EINECS: | 206-064-8 |
Molecular Formula: | C26H28N2 |
Molecular Weight: | 368.56 |
InChI: | InChI=1/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-12,14-18,26H,13,19-22H2/b18-10+ |
Molecular Structure: |
|
Properties |
Density: | 1.093g/cm3 |
Refractive index: | 1.649 |
Appearance: | white powder |
Specification: |
?Cinnarizine (298-57-7) acts by interfering with the signal transmission between the vomiting centre of the hypothalamus and vestibular apparatus of the inner ear?, and could cause drowsiness and blurred vision.?It, which happen mostly in brain, could be also viewed as a nootropic drug because of its vasorelaxating abilities.
|
Storage Temperature: | Refrigerator |
Color: | white |
Usage: | Calcium channel blocker with antiallergic and anti-vasoconstricting activity. Antihistaminic |
Safety Data |
|
|